Azzad Asset Management Inc /Adv Johnson & Johnson Transaction History

Azzad Asset Management Inc /Adv

  • $933 Billion
  • Q2 2025

A detailed history of Azzad Asset Management Inc /Adv transactions in Johnson & Johnson stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 40,858 shares of JNJ stock, worth $7.08 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
40,858
Previous 38,294 6.7%
Holding current value
$7.08 Million
Previous $6.35 Billion 1.73%
% of portfolio
0.67%
Previous 0.75%

Shares

57 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
BUY
$146.36 - $159.82 $375,267 - $409,778
2,564 Added 6.7%
40,858 $6.24 Billion
Q1 2025

Apr 16, 2025
BUY
$142.06 - $167.7 $5.44 Million - $6.42 Million
38,294 New
38,294 $6.35 Billion
Q3 2024

Oct 07, 2024
SELL
$145.48 - $167.38 $1.5 Million - $1.72 Million
-10,291 Reduced 21.66%
37,213 $6.03 Billion
Q2 2024

Jul 30, 2024
BUY
$144.38 - $157.78 $240,248 - $262,545
1,664 Added 3.63%
47,504 $6.94 Billion
Q1 2024

Apr 19, 2024
BUY
$155.22 - $162.74 $114,086 - $119,613
735 Added 1.63%
45,840 $7.25 Billion
Q4 2023

Apr 01, 2024
BUY
$145.6 - $158.88 $93,184 - $101,683
640 Added 1.44%
45,105 $7.07 Billion
Q3 2023

Apr 01, 2024
SELL
$155.75 - $174.48 $487,653 - $546,296
-3,131 Reduced 6.58%
44,465 $6.93 Billion
Q2 2023

Apr 01, 2024
BUY
$154.35 - $166.11 $67,142 - $72,257
435 Added 0.92%
47,596 $7.88 Billion
Q1 2023

Apr 01, 2024
BUY
$151.05 - $180.26 $96,974 - $115,726
642 Added 1.38%
47,161 $7.31 Billion
Q4 2022

Apr 01, 2024
SELL
$160.2 - $179.79 $4.89 Million - $5.48 Million
-30,503 Reduced 39.6%
46,519 $8.22 Billion
Q3 2022

Apr 01, 2024
BUY
$161.33 - $179.52 $175,204 - $194,958
1,086 Added 1.43%
77,022 $11.9 Billion
Q2 2022

Apr 01, 2024
BUY
$168.19 - $186.01 $5.38 Million - $5.95 Million
31,999 Added 72.83%
75,936 $12.3 Billion
Q1 2022

Apr 01, 2024
BUY
$158.14 - $179.59 $802,718 - $911,598
5,076 Added 13.06%
43,937 $7.79 Billion
Q4 2021

Apr 01, 2024
BUY
$155.93 - $173.01 $172,770 - $191,695
1,108 Added 2.93%
38,861 $6.65 Billion
Q3 2021

Apr 01, 2024
BUY
$161.5 - $179.47 $149,872 - $166,548
928 Added 2.52%
37,753 $6.1 Billion
Q2 2021

Apr 01, 2024
BUY
$159.48 - $171.07 $175,428 - $188,177
1,100 Added 3.08%
36,825 $6.07 Billion
Q1 2021

Apr 01, 2024
BUY
$153.07 - $170.48 $106,689 - $118,824
697 Added 1.99%
35,725 $5.87 Billion
Q4 2020

Apr 01, 2024
BUY
$137.11 - $157.38 $182,493 - $209,472
1,331 Added 3.95%
35,028 $5.51 Billion
Q3 2020

Apr 01, 2024
BUY
$140.38 - $153.83 $354,459 - $388,420
2,525 Added 8.1%
33,697 $5.02 Billion
Q2 2020

Apr 01, 2024
BUY
$128.81 - $155.51 $301,801 - $364,359
2,343 Added 8.13%
31,172 $4.38 Billion
Q1 2020

Apr 01, 2024
SELL
$111.14 - $153.99 $3.53 Million - $4.89 Million
-31,778 Reduced 52.43%
28,829 $3.78 Billion
Q4 2019

Apr 01, 2024
BUY
$127.5 - $146.44 $89,250 - $102,508
700 Added 1.17%
60,607 $8.68 Billion
Q3 2019

Apr 01, 2024
BUY
$126.95 - $142.14 $4.33 Million - $4.84 Million
34,070 Added 131.87%
59,907 $8.1 Billion
Q2 2019

Apr 01, 2024
BUY
$131.15 - $144.24 $26,361 - $28,992
201 Added 0.78%
25,837 $3.6 Billion
Q1 2019

Apr 01, 2024
BUY
$125.72 - $139.79 $400,795 - $445,650
3,188 Added 14.2%
25,636 $3.58 Billion
Q4 2018

Apr 01, 2024
SELL
$122.84 - $147.84 $210,547 - $253,397
-1,714 Reduced 7.09%
22,448 $2.9 Billion
Q3 2018

Apr 01, 2024
SELL
$121.58 - $142.88 $130,941 - $153,881
-1,077 Reduced 4.27%
24,162 $3.34 Billion
Q2 2018

Apr 01, 2024
BUY
$119.4 - $131.76 $3.01 Million - $3.33 Million
25,239 New
25,239 $3.06 Billion
Q1 2018

Apr 03, 2024
BUY
$125.1 - $148.14 $242,944 - $287,687
1,942 Added 7.75%
27,012 $3.46 Billion
Q4 2017

Apr 03, 2024
BUY
$131.22 - $143.62 $128,201 - $140,316
977 Added 4.06%
25,070 $3.5 Billion
Q3 2017

Apr 03, 2024
BUY
$129.47 - $135.38 $84,026 - $87,861
649 Added 2.77%
24,093 $3.13 Billion
Q2 2017

Apr 03, 2024
BUY
N/A
659 Added 2.89%
23,444 $3.1 Billion
Q1 2017

Apr 03, 2024
SELL
N/A
-2,787 Reduced 10.9%
22,785 $2.84 Billion
Q4 2016

Apr 03, 2024
BUY
N/A
556 Added 2.22%
25,572 $2.95 Billion
Q3 2016

Apr 03, 2024
SELL
N/A
-691 Reduced 2.69%
25,016 $2.96 Billion
Q2 2016

Apr 03, 2024
BUY
N/A
440 Added 1.74%
25,707 $3.12 Billion
Q1 2016

Apr 03, 2024
BUY
N/A
1,131 Added 4.69%
25,267 $2.73 Billion
Q4 2015

Apr 03, 2024
BUY
N/A
2,179 Added 9.92%
24,136 $2.48 Billion
Q3 2015

Apr 03, 2024
BUY
N/A
2,010 Added 10.08%
21,957 $2.06 Billion
Q2 2015

Apr 03, 2024
SELL
N/A
-3,299 Reduced 14.19%
19,947 $1.94 Billion
Q1 2015

Apr 03, 2024
BUY
N/A
5,040 Added 27.68%
23,246 $2.34 Billion
Q4 2014

Apr 03, 2024
BUY
N/A
1,416 Added 8.43%
18,206 $1.9 Billion
Q3 2014

Apr 03, 2024
BUY
N/A
1,345 Added 8.71%
16,790 $1.79 Billion
Q2 2014

Apr 03, 2024
BUY
N/A
808 Added 5.52%
15,445 $1.62 Billion
Q1 2014

Apr 03, 2024
BUY
N/A
2,233 Added 18.0%
14,637 $1.44 Billion
Q4 2013

Apr 03, 2024
BUY
N/A
682 Added 5.82%
12,404 $1.14 Billion
Q2 2013

Apr 03, 2024
SELL
N/A
-3,352 Reduced 22.24%
11,722 $1.02 Billion
Q1 2013

Apr 03, 2024
SELL
N/A
-30,031 Reduced 66.58%
15,074 $1.23 Billion
Q4 2012

Apr 08, 2024
BUY
N/A
141 Added 1.04%
13,675 $959 Million
Q3 2012

Apr 08, 2024
BUY
N/A
4,308 Added 46.69%
13,534 $933 Million
Q2 2012

Apr 08, 2024
BUY
N/A
2,167 Added 30.7%
9,226 $623 Million
Q1 2012

Apr 08, 2024
BUY
N/A
1,517 Added 27.37%
7,059 $466 Million
Q4 2011

Apr 08, 2024
SELL
N/A
-1,431 Reduced 20.52%
5,542 $363 Million
Q3 2011

Apr 08, 2024
BUY
N/A
230 Added 3.41%
6,973 $444 Million
Q2 2011

Apr 08, 2024
SELL
N/A
-3,167 Reduced 31.96%
6,743 $449 Million
Q1 2011

Apr 08, 2024
SELL
N/A
-479 Reduced 4.61%
9,910 $587 Million
Q4 2010

Apr 08, 2024
SELL
N/A
-34,716
10,389 $643 Million

Others Institutions Holding JNJ

# of Institutions
4,629
Shares Held
1.72B
Call Options Held
25M
Put Options Held
15.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $453B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email